Ratio Therapeutics Inc, a Boston-based pharmaceutical company, announced on Tuesday that it has named Bill Cupelo as its new chief business officer and D. Scott Holbrook, MS, FSNMMI-TS as its new director.

Cupelo has more than 10 years of experience in sales with a focus on oncology and neurology. He has served as head of Sales at Invicro and vice president of Business Development and Strategic Accounts, and software product manager at Invicro.

Holbrook has 25 plus years of experience in the field of molecular imaging and therapeutics. Presently, he serves as the general manager and chief strategy officer at PharmaLogic.